Universal Health Services B earnings beat by $0.02, revenue topped estimates

Universal Health Services (UHS) reported Q3 EPS of $5.22, beating estimates by $0.02, with revenue at $4.73B, exceeding expectations. The stock is up 5.27% in 3 months but down 19.15% in 12 months. InvestingPro rates its financial health as 'great performance'.

Original reporting
Published Oct 27, 2026, 8:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$UHS
Bearish
high confidence
Mentioned
$UHS
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$UHSBearishMed
01

Why it matters

The modest beat could generate short-term buying interest but limited upside without forward guidance.

02

Market read

UHS earnings beat offers a small positive catalyst for the stock and its sector.

03

What to watch

No guidance was provided; future outlook remains uncertain.

Relevance 8/10Novelty 8/10Timing: post-market release

Background

Universal Health Services B (UHS) posted Q3 results with a slight earnings and revenue beat.

Company-level read

Ticker impact

$UHSBearishHigh confidence
Context

UHS reported Q3 EPS of $5.22 beating estimates by $0.02 and revenue of $4.73B beating forecasts.

Expected impact

likely modest upward pressure as investors price in the beat

Evidence & confidence

The beat is small but positive; market typically reacts favorably to any earnings beat.

Market effects

Healthcare services sector may see slight uplift from a large provider's beat.

U.S. markets may see modest positive bias in hospital REITs.

Limited; primarily U.S. investors.

Counterpoint

The beat is marginal and may not be enough to sustain a rally.

Key entities

  • Universal Health Services B

    Provider of hospital and behavioral health services.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$CNCMed

Health insurers, hospitals rally after sweeping midterm win for Democrats

Shares of Medicaid-focused health insurers (Centene, Elevance, Molina) and hospital operators (HCA, Tenet, Universal) rose after Democrats won the midterms, raising hopes for sector-friendly policies. Analysts expect delays in Trump's OBBBA, easing pressure on Medicaid and ACA insurers, and potential extensions of enhanced subsidies. Year-to-date gains vary among companies.

$UHSHighAI 8/10

Softer surgery volumes, hospital woes dampened UHS’ Q3 earnings

Universal Health Services (UHS) lowered its 2026 earnings expectations due to declining surgeries and struggles at some hospitals. Q3 net income fell 17% to $308M, while revenues rose 5% to $4.7B. Challenges include lower surgery volumes, delays in new hospital profitability, and rising uninsured patients. UHS expects to be at the lower end of its guidance range for 2024.

$UHSMed

Guggenheim cuts Universal Health Services stock price target to $201 on weak Q3

Guggenheim reduced its price target for Universal Health Services (UHS) to $201 from $209, citing weak Q3 2026 EBITDA and macro pressures. UHS stock is down 8.5% in a week. The company lowered its 2026 EBITDA guidance but sees potential upside from expansions. UHS reported Q3 EPS of $5.22 and revenue of $4.73B, slightly beating estimates. Raymond James kept a Market Perform rating, noting softer profit trends and a cautious 2027 outlook.